Therefore, toxic metabolites of anti-TB drugs may induce the methylation of the promoter regions of GSTP1 or CYP1A1 by increasing the activity of DNMT1, DNMT3a, and DNMT3b. Here, CYP1A1 is linked to tuberculosis.